Ljungman, P. Et Al. 2023. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.. Frontiers in immunology , vol.14 , 1125824.

Ljungman, P., Tridello, G., Piñana, J. L., Ciceri, F., Sengeloev, H., Kulagin, A., ... Mielke, S.(2023). Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.. Frontiers in immunology , vol.14, 1125824.

Ljungman, Per Et Al. "Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.," Frontiers in immunology , vol.14, 1125824, 2023

Ljungman, Per Et Al. "Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.." Frontiers in immunology , vol.14, pp.1125824, 2023

Ljungman, P. Et Al. (2023) . "Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.." Frontiers in immunology , vol.14, p.1125824.

@article{article, author={Per Ljungman Et Al. }, title={Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.}, journal={Frontiers in immunology}, year=2023, pages={1125824} }